Amarin Corp Plc (AMRN)

[sts66]

There is a smoking gun in that damn research paper - it basically says MO caused those biomarkers to go up and even questions R-IT results - it doesn't get worse than this, and they were backstabbed by their own experts, including Bhatt.

CONCLUSIONS:

Among participants in REDUCE-IT, allocation to icosapent ethyl had minimal effects on a series of biomarkers associated with atherosclerotic disease, whereas levels increased among those allocated to mineral oil. The effect of these findings on interpretation of the overall risk reductions in clinical events observed within REDUCE-IT is uncertain.